Patent holdings for IPC class A61K 45/06

Total number of patents in this class: 45298

10-year publication summary

4074
4010
4318
4162
4366
4655
4156
3685
3706
2824
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
10685
605
The Regents of the University of California
20195
467
Merck Sharp & Dohme LLC
3737
342
Genentech, Inc.
4014
328
Board of Regents, The University of Texas System
5906
325
Dana-Farber Cancer Institute, Inc.
2607
305
Bristol-myers Squibb Company
4847
304
Gilead Sciences, Inc.
2064
299
Boehringer Ingelheim International GmbH
4632
272
The Johns Hopkins University
5731
234
Regeneron Pharmaceuticals, Inc.
4377
217
The Board of Trustees of the Leland Stanford Junior University
6507
212
Inserm (institut National de La Sante et de La Recherche Medicale)
3369
208
Emory University
1646
202
The General Hospital Corporation
4789
197
Institut National de La Sante et de La Recherche Medicale (inserm)
2945
193
Pfizer Inc.
3379
191
Centre National de La Recherche Scientifique
10632
191
The United States of America, as represented by the Secretary, Department of Health and Human Services
2892
189
Yale University
2424
184
Other owners 39833